---
figid: PMC11313229__ijms-25-08461-g003
figtitle: Natural Products in the progression of ROP
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11313229
filename: ijms-25-08461-g003.jpg
figlink: /pmc/articles/PMC11313229/figure/F3
number: F3
caption: 'Mechanisms of Natural Products in the progression of ROP. The Regulatory
  mechanisms of natural compounds discussed in this article are demonstrated at the
  cellular level. Natural compounds act as inhibitors of angiogenesis by regulating
  angiogenesis-related receptors or engaging various signaling pathways. Activation
  is indicated by pointed arrows, while inhibition is represented by T-bars. Abbreviations:
  AHX, 2-Azahypoxanthine; AKBA, acetyl-11-keto-b-boswellic acid; A2AR, adenosine A2A
  receptor; APN, adiponectin; AKT, protein kinase B; AT2R, angiotensin II receptor;
  ERK, extracellular signal-regulated kinase; HIF1α, hypoxia-inducible factor 1α;
  MMP, matrix metalloproteinase; PDGFR-β, platelet-derived growth factor β; PI3K,
  phosphatidylinositol 3-kinase; SHP-1, Src homology region 2 domain-containing phosphatase
  1; STAT3, signal transducer and activator of transcription 3 VEGFR2, vascular endothelial
  growth factor receptor 2'
papertitle: 'Natural Products in the Treatment of Retinopathy of Prematurity: Exploring
  Therapeutic Potentials'
reftext: Jong-Ik Heo, et al. Int J Mol Sci. 2024 Aug;25(15).
year: '2024'
doi: 10.3390/ijms25158461
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: natural products | angiogenesis | retinopathy of prematurity | retinal vascular
  disease
automl_pathway: 0.9724169
figid_alias: PMC11313229__F3
figtype: Figure
redirect_from: /figures/PMC11313229__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11313229__ijms-25-08461-g003.html
  '@type': Dataset
  description: 'Mechanisms of Natural Products in the progression of ROP. The Regulatory
    mechanisms of natural compounds discussed in this article are demonstrated at
    the cellular level. Natural compounds act as inhibitors of angiogenesis by regulating
    angiogenesis-related receptors or engaging various signaling pathways. Activation
    is indicated by pointed arrows, while inhibition is represented by T-bars. Abbreviations:
    AHX, 2-Azahypoxanthine; AKBA, acetyl-11-keto-b-boswellic acid; A2AR, adenosine
    A2A receptor; APN, adiponectin; AKT, protein kinase B; AT2R, angiotensin II receptor;
    ERK, extracellular signal-regulated kinase; HIF1α, hypoxia-inducible factor 1α;
    MMP, matrix metalloproteinase; PDGFR-β, platelet-derived growth factor β; PI3K,
    phosphatidylinositol 3-kinase; SHP-1, Src homology region 2 domain-containing
    phosphatase 1; STAT3, signal transducer and activator of transcription 3 VEGFR2,
    vascular endothelial growth factor receptor 2'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PDGFRB
  - PDGFRA
  - KDR
  - ADORA2A
  - AGTR2
  - PGR-AS1
  - PTPN6
  - STAT3
  - EPHB2
  - MAPK1
  - MAPK3
  - NR0B1
  - AKT1
  - AKT2
  - AKT3
  - ANPEP
  - MMP2
  - MMP9
  - IGBP1
  - Chlorogenic acid
  - Baicalin
  - AHX
  - Honokiol
  - Luteolin
  - Caffeic acid
  - Caffeine
  - Resveratrol
  - Astaxanthin
---
